We are live on ! Find out more
FBRX icon

Forte Biosciences

63 hedge funds and large institutions have $92M invested in Forte Biosciences in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

79% more capital invested

Capital invested by funds: $51.5M → $92M (+$40.5M)

73% more call options, than puts

Call options by funds: $636K | Put options by funds: $367K

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

3% more funds holding

Funds holding: 6163 (+2)

0.01% more ownership

Funds ownership: 0.07%0.08% (+0.01%)

Holders
63
Holders Change
+2
Holders Change %
+3.28%
% of All Funds
1.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
21
Reduced
10
Closed
10
Calls
$636K
Puts
$367K
Net Calls
+$269K
Net Calls Change
+$46K
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$604K +$87.6K +23 +29%
CG
27
Colony Group
Massachusetts
$579K
AA
28
ALPS Advisors
Colorado
$550K +$64.7K +17 +22%
TA
29
Teachers Advisors
New York
$531K -$3.81K -1 -1%
Wells Fargo
30
Wells Fargo
California
$488K +$3.81K +1 +1%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$481K +$312K +82 New
BP
32
BBR Partners
New York
$429K
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$429K
TD Asset Management
34
TD Asset Management
Ontario, Canada
$370K +$57.1K +15 +31%
Goldman Sachs
35
Goldman Sachs
New York
$356K -$22.8K -6 -9%
Citigroup
36
Citigroup
New York
$354K +$228K +60 New
Stifel Financial
37
Stifel Financial
Missouri
$307K +$202K +53 New
JMPWA
38
JP Morgan Private Wealth Advisors
California
$282K
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$268K
GJIC
40
Gamble Jones Investment Counsel
California
$264K -$3.81K -1 -2%
Citadel Advisors
41
Citadel Advisors
Florida
$251K +$164K +43 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$241K -$11.4K -3 -7%
WJA
43
Williams Jones & Associates
New York
$218K -$15.2K -4 -10%
BFA
44
Beaumont Financial Advisors
Massachusetts
$212K +$137K +36 New
AIG
45
American International Group
New York
$184K +$3.81K +1 +3%
Bank of America
46
Bank of America
North Carolina
$177K +$60.9K +16 +114%
SWP
47
Stratos Wealth Partners
Ohio
$164K
UBS Group
48
UBS Group
Switzerland
$162K +$34.3K +9 +47%
ProShare Advisors
49
ProShare Advisors
Maryland
$161K -$3.81K -1 -3%
Barclays
50
Barclays
United Kingdom
$105K +$53.3K +14 +350%

FBRX Hedge Fund Activity: Q3 2018 in Review

63 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q3 2018, worth a combined $92M — up 79% from $51.5M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new FBRX positions and 10 closed out — a net gain of 2 holders — while 21 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $2.89M. The largest seller was BVF Inc, exiting entirely with an estimated $4.4M sold.

  • 63 institutional investors held Forte Biosciences (FBRX) as of Q3 2018, up from 61 in Q2 2018.
  • Funds reported $92M of Forte Biosciences stock for Q3 2018, up 79% quarter-over-quarter.
  • 12 funds opened new Forte Biosciences positions in Q3 2018 and 10 closed out, a net change of +2 holders.
  • The largest Forte Biosciences buyer in Q3 2018 was BlackRock, an estimated $2.89M added.
  • The largest Forte Biosciences seller in Q3 2018 was BVF Inc, an estimated $4.4M sold.

Based on aggregated 13F filings for Q3 2018.